Clinical Trial Update: Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)

View source ↗

Summary

This completed clinical trial evaluated the risk of nephrogenic systemic fibrosis in patients with chronic kidney disease who had no exposure to gadolinium-base…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Nephrogenic Systemic Fibrosis

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Renal Insufficiency | Status: COMPLETED